<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective AnalysisJustin F. Gainor, Mari Mino–Kenudson, Alice T. Shaw et al.|Clinical Cancer Research|2016Cited by 1.2k
Cycling cancer persister cells arise from lineages with distinct programsYaara Oren, Aviv Regev, Michael Tsabar et al.|Nature|2021Cited by 514
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung CancerAnna F. Farago, Benjamin J. Drapkin, Beow Y. Yeap et al.|Cancer Discovery|2019Cited by 238
Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived XenograftsBenjamin J. Drapkin, Anna F. Farago, Julie George et al.|Cancer Discovery|2018Cited by 216
Therapy-induced APOBEC3A drives evolution of persistent cancer cellsHideko Isozaki, Aaron N. Hata|Nature|2023Cited by 143